Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Lucid Diagnostics Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 33 | 49 | +16 |
| Shares | 3.31M | 9.39M | +6.08M (+183.5%) |
| Value | $2.70M | $14.0M | +$11.3M (+417.0%) |
New holders (20)
Institutions that held Lucid Diagnostics Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Masters Capital Management LLC | 2,727,273 | $4.06M | 0.86% |
| Alyeska Investment Group, L.P. | 1,887,843 | $2.81M | 0.01% |
| Renaissance Technologies LLC | 459,065 | $684.0K | 0.00% |
| Ghisallo Capital Management LLC | 422,004 | $628.8K | 0.05% |
| Millennium Management LLC | 204,047 | $304.0K | 0.00% |
| Susquehanna International Group, LLP | 190,455 | $283.8K | 0.00% |
| XML Financial, LLC | 178,795 | $266.4K | 0.02% |
| Squarepoint Ops LLC | 30,522 | $45.5K | 0.00% |
| Cubist Systematic Strategies, LLC | 26,048 | $38.8K | 0.00% |
| Northwestern Mutual Wealth Management Co | 24,559 | $36.6K | 0.00% |
| Berkshire Asset Management LLC | 20,000 | $23.8K | 0.00% |
| Obermeyer Wood Investment Counsel, LLLP | 13,000 | $19.4K | 0.00% |
| Pine Valley Investments Ltd Liability Co | 11,296 | $16.8K | 0.00% |
| Mariner, LLC | 10,163 | $15.1K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 10,000 | $15.0K | 0.00% |
| UBS Group AG | 5,850 | $8.72K | 0.00% |
| Barclays PLC | 1,584 | $2.36K | 0.00% |
| FMR LLC | 555 | $827 | 0.00% |
| Federation des caisses Desjardins du Quebec | 35 | $52 | 0.00% |
| Binnacle Investments Inc | 25 | $37 | 0.00% |
Sold out (4)
Institutions that held Lucid Diagnostics Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Geneos Wealth Management Inc. | 29,550 | $24.2K |
| XTX Topco Ltd | 25,322 | $20.7K |
| Two Sigma Securities, LLC | 19,316 | $15.8K |
| Jane Street Group, LLC | 13,819 | $11.3K |